SAN FRANCISCO, Sept. 1, 2023 /PRNewswire/ — The U.S. Health & Human Services Department (HHS) recommendation to reschedule cannabis from a Schedule I to a Schedule III drug1 will transform the cannabis industry and create new opportunities for banking and financial services providers….